In contrast to fibroblasts, the exposure of GO/Gl-arrested (6) and activation of the Na+/H+-antiport system leading to alkalinization of the cytosol (7). However, unlike these other mitogenic peptides, thrombin is a serine esterase whose function as a growth stimulator, at least for fibroblasts, is intimately linked to its esterolytic activity. Thus, while native a-thrombin is capable of evoking DNA synthesis in GO/Gl-arrested cells, neither enzymatically inactive thrombin [i.e., diisopropyl phosphorofluoridate (iPr2P-F)-conjugated a-thrombin] nor partially degraded thrombin (i.e., y-thrombin) share in this capability (3) (4) (5) . Recent data from our laboratory have shown that thrombin is chemotactic for peripheral blood monocytes and cells belonging to the monocyte/macrophage family and that this activity is not dependent upon thrombin's enzymatic properties (8-11). We wondered therefore, whether thrombin might also serve as a growth factor for these cells and, if so, whether this mitogenic capability would be independent of esterolytic function. In this communication, we present data that (i) establishes enzymatically inactive thrombin as a growth factor for cells of macrophage lineage and (ii) localizes this growth-promoting site within or near the "loop B" insertion sequence (12) of the thrombin B chain.
incorporation. This response to thrombin is optimal at 10 nM and is specifically blocked by hirudin, a high-affinity thrombin inhibitor. When prethrombin 1 [a single-chain prothrombin derivative lacking fragment 1, resulting from the action of thrombin on prothrombin] is cleaved with cyanogen bromide, a fragment (peptide CB67-129) is produced that, like the parent thrombin molecule, is mitogenic for J774 cells but not for fibroblasts. Limited tryptic digests of this fragment retain the ability to stimulate macrophages-a function that can be mimicked by a synthetic tetradecapeptide homologue of CB67-129 (representing residues 367-380 of the human thrombin B chain sequence) but not by any of a series of well-known growth promoters, including platelet-derived growth factor, epidermal growth factor, nerve growth factor, and fibroblast growth factor. The mitogenic effects of this peptide are not limited to J774 cells but can be expressed in other macrophagelike tumor cell lines, including P388D1, RAW, and PU5. In addition to increased [3H]thymidine incorporation, the synthetic B chain peptide stimulates cell proliferation as evidenced by a dose-dependent increase in total protein per culture well and cell number. We conclude that the thrombin molecule contains a macrophage growth factor domain that is separate and distinct from its active center. Thus, thrombin, in addition to its major role in hemostasis and thrombosis, may also have important functions in such basic processes as the inflammatory response and monocytopoiesis.
It has been recognized for many years that a-thrombin, the enzymatically active form of thrombin (EC 3.4.21.5), like other better-known mitogens [e.g., platelet-derived growth factor (PDGF), epidermal growth factor (EGF), etc.], is capable of initiating proliferation in quiescent cells belonging to the fibroblast family (1) (2) (3) (4) (5) . As with other growth factors, this stimulation results in enhanced phosphorylation ofthe S6 ribosomal protein (6) and activation of the Na+/H+-antiport system leading to alkalinization of the cytosol (7). However, unlike these other mitogenic peptides, thrombin is a serine esterase whose function as a growth stimulator, at least for fibroblasts, is intimately linked to its esterolytic activity. Thus, while native a-thrombin is capable of evoking DNA synthesis in GO/Gl-arrested cells, neither enzymatically inactive thrombin [i.e., diisopropyl phosphorofluoridate (iPr2P-F)-conjugated a-thrombin] nor partially degraded thrombin (i.e., y-thrombin) share in this capability (3) (4) (5) .
Recent data from our laboratory have shown that thrombin is chemotactic for peripheral blood monocytes and cells belonging to the monocyte/macrophage family and that this activity is not dependent upon thrombin's enzymatic properties (8) (9) (10) (11) . We wondered therefore, whether thrombin might also serve as a growth factor for these cells and, if so, whether this mitogenic capability would be independent of esterolytic function. In this communication, we present data that (i) establishes enzymatically inactive thrombin as a growth factor for cells of macrophage lineage and (ii) localizes this growth-promoting site within or near the "loop B" insertion sequence (12) [methyl-3H(N)]thymidine (1 gCi/ml). The cells were washed three times in phosphate-buffered saline (140 mM NaCl/3 mM KCl/8 mM Na2HPO4/1 mM K2HPO4/1 mM CaCl2/5 mM MgCl2, pH 7.4) at 40C and lysed with 10% CCl3COOH (30 min at 40C); the CCl3COOH-insoluble material was extracted twice with ETOH:ET2O, 3:1 (vol/vol). The precipitate was solubilized in 1 M NaOH, and aliquots were withdrawn for protein determinations using a dye-binding assay (Bio-Rad) and liquid scintillation spectrometry.
Peptide Synthesis. Tetradecapeptide H-Tyr-Pro-Pro-TrpAsn-Lys-Asn-Phe-Thr-Glu-Asn-Asp-Leu-Leu-OH, representing residues 367-380 of the human thrombin B chain 1 1 and containing the loop B insertion sequence (see Fig. 2 ), was synthesized by a modification of the method of Merrifield as described (17, 18) . The fully protected peptide was simultaneously deprotected and cleaved from its resin support by the two-step HF-catalyzed SN2 procedure described by Tam et al. (19) . The crude peptide was definitively purified by ion-exchange chromatography on a DEAE-Sephacel column as described (17) . Peptide purity was ascertained by reversed-phase (C18) HPLC (15) during which it migrated as a single peak. The peptide was also found to be homogeneous by TLC, mi-rating as a single spot in two different solvent systems (17, 18) . Amino acid analysis yielded the expected molar ratios.
RESULTS
The addition of active but not esterolytically inactive thrombin (iPr2P-F-conjugated a-thrombin) stimulated DNA synthesis in CHL fibroblasts (Fig. 1A) . This finding is in contrast to that obtained with the murine macrophage-like cell line J774 as well as with other macrophage cell lines (i.e., P388D1, RAW, and PU5; data not shown), wherein both forms of thrombin were seen to enhance markedly (>100%) the incorporation of [3H]thymidine into quiescent cells (Fig. 1A) as well as to stimulate cell proliferation (data not shown). The mitogenic effect of thrombin was observed over a wide range of concentrations (10 pM to 1 ,M) but was optimal at 10 ,uM. Both forms of thrombin elicited the same degree of response in J774 cells and were specifically blocked in their ability to stimulate [3H]thymidine incorporation by prior complexing with hirudin, a leech-derived thrombin inhibitor (Fig. 1B) . This apparent specificity of thrombin as a macrophage mitogen was further emphasized by the failure of other known growth-promoting agents, including PDGF, EGF, NGF, and FGF at concentration ranges of up to 500 ng/ml, to elicit proliferation in these cells ( Table 1 ).
The observation that thrombin promoted cell division in J774 cells independently of its esterolytic function and that such activity was inhibitable by hirudin suggests that the region in thrombin responsible for these effects may either coincide with or overlap the thrombin chemotactic exosite (9, 10) . To test this hypothesis. the thrombin-derived chemotactic fragment (10) peptide CB67-129 (Fig. 2) was assessed for its ability to act as a mitogen. Peptide CB67-129 stimulated tion range of 10 pM to 1 M, with optimal stimulation occurring at 10 nM (Fig. 3A) . The degree of response elicited with this cyanogen bromide-derived fragment was, at a minimum, equal to that elicited with either active or enzymatically inactive thrombins when both were tested at their optimal concentrations. CB67-129 had no stimulatory effect on CHL fibroblasts.
To determine whether the mitogenic effects of the CNBr peptide might be expressed by smaller peptide fragments, the lysine groups of CB67-129 were reversibly blocked by citraconylation (14) ; then the peptide was digested with trypsin. Under these conditions, cleavage of peptide CB67-129 was limited exclusively to sites containing arginyl bonds. After removal of the lysine side-chain-blocking groups, the resultant digest was tested for J774 mitogenic ' Prothrombin nomenclature (16 (Fig. 3A) . Fractionation of the digest by reversed-phase HPLC provided evidence suggesting that activity was present in fractions containing residues 356-382 (Fig. 2) (12) . The sequence nomenclature used is that of prothrombin (16), a single chain zymogen, which is subsequently activated and cleaved into a two-chain structure at residues 272 and 321 by factor Xa (20) . The active enzyme so produced deletes the first 13 residues of the A chain at residue 285 by an autocatalytic event (20) , yielding a-thrombin. (20, 21) . principally by the presence of a unique 9'-10 residue insertion sequence termed "loop B" (21, 22) (Fig. 2) .
To establish whether the loop B sequence itself might account for the biological activity of the parent CB67-129 peptide, a loop B-containing homologue of the CNBr fragment [representing residues 367-380 of the human thrombin B chain (Fig. 2) ] was synthesized, and its ability to stimulate mitogenic activity and cell proliferation in J774 cells was determined. This synthetic peptide was capable of stimulating both [3H]thymidine incorporation and protein synthesis in G0/G1-arrested J774 cells over a concentration range paralleling that of both thrombin and CB67-129, with optimal stimulation occurring at 10 nM (Fig. 3B) . Concomitant with these changes was a dose-dependent increase in cell proliferation. As an example, in a representative experiment, 24 hr after exposure of the growth-arrested cells to optimal concentrations of this peptide (i.e., 10 nM), cell numbers increased approximately 2-fold from a control value of 1.2 to 2 x 1i0 cells per culture well. The ability of this peptide to stimulate cell proliferation is shown in Fig. 4 . Moreover, this growth-promoting effect was not limited to J774 cells; other murine macrophage-like cell lines including P388D1, RAW, and PU5, were likewise stimulated by this synthetic peptide (Table 1) . Thus, the loop B region in the thrombin molecule appears responsible, at least in part, for the nonesterolytic macrophage-growth factor activity exhibited by enzymatically inactive thrombin.
DISCUSSION
Thrombin is a serine protease that plays a central role in initiating procoagulant events. This role includes the conversion of fibrinogen to fibrin (20) , the stimulation of platelet aggregation and release reactions (23) , and the mobilization of arachidonate pathway metabolites from endothelial cells (24) . Since assembly of the prothrombin activation complex may occur on the cell membranes of mononuclear inflammatory cells (25) , it is not surprising that significant amounts of active thrombin accumulate in the fluid phase of the fibrin gel (26, 27) , in part, because some of the latter cells are trapped or migrate into the gel during the early phases of wound healing. Thus, thrombin is both a product of and available to the broad variety of cells, both inflammatory and reparative, that are involved in the wound-healing process.
Studies from Buchanan's laboratory were the first to demonstrate that thrombin is mitogenic for avian fibroblasts (1). Subsequently, this finding was extended to fibroblasts from other species and was found to depend upon thrombin's activity as a protease (2, 3, 5) . In the present study, we provide conclusive evidence that thrombin also functions as a mitogen for several macrophage-like tumor cell lines and that, in contrast to the situation in fibroblasts, thrombin's ability to stimulate growth-arrested macrophages is entirely independent of its enzymic activity. In addition, we have localized the macrophage mitogenic site to the same region of the thrombin B chain [i.e., residues 338-400 (Fig. 2) (Fig. 2) ], the majority of this sequence is probably surface-expressed [corroborated by computer modeling studies (28) ] and therefore available for interacting with cell-surface receptors. In addition, this region of the thrombin B chain contains the loop B insertion sequence (Fig. 2) , a unique structural feature of the thrombin molecule that is absent from two closely related (but chemotactically inactive) serine esterases, chymotrypsin and trypsin, with otherwise high degrees of sequence homology to thrombin (22) . On the basis of these observations, we theorized that the loop B insertion sequence is critical to the expression of thrombin's chemotactic activity and mitogenic potential. In fact, the latter assumption is supported by the following findings: (i) native a-thrombin, esterolytically inactive iPr2P-F-a-thrombin, and fragment CB67-129 are approximately equivalent in their abilities to stimulate proliferation in growth-arrested macrophages; (ii) (32, 33) . Although sequence data for CSF-1 is unavailable, no significant homology is apparent between GM-CSF, whose sequence is known, and the growth-promoting region in thrombin (33) . Moreover, preliminary unpublished data from this laboratory (R.B.-S.) indicate that purified murine CSF-1 fails to stimulate proliferation of growth-arrested J774 cells. These findings are consistent with the relatively low number of CSF-1 receptors present on this cell [in comparison to CSF-1-responsive cells (34) ] and further suggest that CSF-1 and thrombin interact with different receptor sites on the J774 cell membrane.
